Small Molecules

10 Aug 2007 GSK receives decision from FDA on Advair 500/50 for COPD
10 Aug 2007 DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10 Aug 2007 Sirtris Pharmaceuticals, Inc. Announces Initiation of Phase 1b Clinical Trial of SRT501 in MELAS
10 Aug 2007 Spectrum Pharmaceuticals Investigational New Drug Application for SPI-1620 Cleared by U.S. Food & Drug Administration
10 Aug 2007 Phase I intravenous trial for anti-cancer drug achieves primary objectives
10 Aug 2007 Phase II Study of IMC-11F8 for Advanced Colorectal Cancer Has Commenced Patient Enrollment in Europe
09 Aug 2007 Lux granted fast track designation by FDA for LX211 for the treatment of uveitis
09 Aug 2007 Update on clinical trials of belinostat
09 Aug 2007 FermaVir announces positive data from recent preclinical studies of FV-100
09 Aug 2007 Neuromed Announces that Merck & Co., Inc. Discontinues Development of Pain Drug Candidate, Joint Research Program Continues
09 Aug 2007 Avexa positioned to launch Phase III clinical trial of ATC
09 Aug 2007 Abraxis BioScience Announces Licensing Agreement with Biocon Limited for the Commercialization of ABRAXANE in India
08 Aug 2007 TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
08 Aug 2007 Bionomics to develop cancer drug target BNO69 with support from the Cancer Therapeutics CRC
08 Aug 2007 EPIX Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of First-in-Class 5-HT2B Antagonist in Patients with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
08 Aug 2007 Health Canada Approves Sativex(R) For Cancer Pain
08 Aug 2007 KineMed and Merck Enter Collaboration in Atherosclerosis
07 Aug 2007 Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
07 Aug 2007 CeNeS Licenses New Intravenous Anaesthetic to Ono in Japan
07 Aug 2007 Prana Provides an Update on the Phase IIa Trial of PBT2 in Patients with Alzheimer's Disease
07 Aug 2007 Indevus Announces FDA Approval of SANCTURA(R) XR
07 Aug 2007 Bayer HealthCare and Nektar Therapeutics Launch Global Development and Commercialization Agreement to Fight Gram-Negative Pneumonias
07 Aug 2007 Pfizer's Selzentry(TM) (Maraviroc) Tablets, Novel Treatment for HIV, Approved by FDA
04 Aug 2007 FDA allows long term use of ISA247 in Isotechnika Phase 2b kidney transplant trial
04 Aug 2007 Hana Biosciences Initiates Marqibo(R) Phase 2 Clinical Trial in Relapsed Acute Lymphoblastic Leukemia (All)

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up